Diabetes data in Kazakhstan shows encouraging trends but raises questions about healthcare system effectiveness

Recent diabetes morbidity data from Kazakhstan shows a slight decrease in cases per 100,000 population in early 2026 compared to 2025, attributed to increased HbA1c testing. While this indicates improved monitoring, researchers note it primarily reflects the healthcare system's actions rather than the ultimate well-being of patients, highlighting a broader systemic issue.

Read the full article at Vlast.kz →

Headline and summary written by daryo. The full report belongs to Vlast.kz.